What is the current generic drugs market size and how fast is it growing?

The generic drugs market size stands at USD 431.10 billion in 2025 and is projected to reach USD 611.17 billion by 2030 at a 7.23% CAGR. Read More

Which therapeutic segment is expanding quickest within the generic drugs market?

Oncology generics top growth charts with a 9.21% CAGR, buoyed by biosimilar launches for high-cost monoclonal antibodies. Read More

Why do injectables dominate revenue despite high manufacturing hurdles?

Hospitals rely on sterile injections for critical care, and five suppliers with established aseptic capacity collectively hold 46% of this subsegment’s generic drugs market share. Read More

How will the Inflation Reduction Act affect US generic pricing?

Drug price negotiations beginning in 2026 will push down reference prices, squeezing margins and compelling producers to streamline operations. Read More

Which region offers the strongest growth prospects?

Asia-Pacific is forecast to achieve an 8.19% CAGR through 2030, underpinned by expanding healthcare access and accelerating regulatory harmonization. Read More

What risks do manufacturers face from regulatory oversight?

Heightened FDA inspections and warning letters for data integrity breaches can trigger production halts, temporarily redistributing demand to compliant rivals. Read More

Generic Drugs Companies

This report lists the top Generic Drugs companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Generic Drugs industry.

About This Report
- Market Size & Share
- Market Analysis
- Trends and Insights
- Segment Analysis
- Geography Analysis
- Competitive Landscape
- Major Players
- Recent Developments
Table of Contents
SCOPE OF THE REPORT
Market Definition